Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Mineralys Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 87 | +11 |
| Shares | 26.5M | 568.4K | 34.7M | +8.77M (+33.8%) |
| Value | $252.1M | $5.41M | $298.5M | +$51.8M (+21.0%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (12)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| RTW Investments, LP | 922,100 | $8.77M |
| Janus Henderson Group PLC | 665,717 | $6.34M |
| Schonfeld Strategic Advisors LLC | 192,362 | $1.83M |
| Jane Street Group, LLC | 43,057 | $409.5K |
| Occudo Quantitative Strategies LP | 22,489 | $213.9K |
| XTX Topco Ltd | 18,670 | $177.6K |
| Ghisallo Capital Management LLC | 10,000 | $95.1K |
| Deutsche Bank AG | 5,678 | $54.0K |
| Allspring Global Investments Holdings, LLC | 1,663 | $15.8K |
| Riverview Trust Co | 1,353 | $12.9K |
| Umb Bank N A | 1,046 | $9.95K |
| Huntington National Bank | 166 | $1.54K |
Not filed for Q4 2023 yet (1)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 568,379 | $5.41M |